Context: Immune functions seem to have connections to variations in body fat mass. Studies of knockout mice indicate that endogenous interleukin (IL)-1 can suppress mature-onset obesity. Objective: To systematically investigate our hypotheses that single-nucleotide polymorphisms (SNPs) and/or haplotypes variants in the IL-1 gene system are associated with fat mass. Subjects: The Gothenburg osteoporosis and obesity determinants (GOOD) study is a population-based cross-sectional study of 18-20 year-old men (n ¼ 1068), from Gothenburg, Sweden. Major findings were confirmed in elderly men (n ¼ 3014) from the Swedish part of the osteoporotic fractures in men (MrOS) multicenter population-based study. Main Outcome Measure: The genotype distributions and their association with body fat mass in different compartments, measured with dual-energy X-ray absorptiometry (DXA). Results: Out of 15 investigated SNPs in the IL-1 receptor antagonist (IL1RN ) gene, a recently identified 3 0 untranslated region C4T (rs4252041, minor allele frequency ¼ 4%) SNP was associated with the primary outcome total fat mass (P ¼ 0.003) and regional fat masses, but not with lean body mass or serum IL-1 receptor 1 (IL1RN) levels. This SNP was also associated with body fat when correcting the earlier reported IL1RN þ 2018 T4C (rs419598) SNP (in linkage disequilibrium with a well-studied variable number tandem repeat of 86 bp). The association between rs4252041 SNP and body fat was confirmed in the older MrOS population (P ¼ 0.03). The rs4252041 SNP was part of three haplotypes consisting of five adjacent SNPs that were identified by a sliding window approach. These haplotypes had a highly significant global association with total body fat (Po0.001). None of the other investigated members of the IL-1 gene family displayed any SNPs that have not been described previously to be significantly associated with body fat. Conclusions: The IL1RN gene, shown to enhance obesity by suppressing IL-1 effects in experimental animals, have no previously described gene polymorphisms and haplotypes that are associated with fat, but not lean mass in two populations of men.
Introduction
The interleukin-1 (IL-1) system was initially identified as an important regulator of inflammation, but it has recently also been implicated in the regulation of metabolic functions, including obesity. The IL-1 system has several components, including two agonists, IL-1b and the less potent IL-1a. The biological effects are exerted through the IL-1 receptor 1 (IL1R1). The binding of IL-1 to IL1R1 can be inhibited by the endogenous IL-1 receptor antagonist (IL1RN). Although IL-1a and IL-1b have short half lives and are difficult to measure outside the site of an inflammation, IL1RN has a relatively longer half life and is found in substantial amounts in the circulation. 1 The circulating IL1RN has been regarded as an acute phase reactant released from the liver, 2 but IL1RN is also released from fat tissue, especially in obese individuals. 3, 4 The balance between IL-1 and IL1RN is regarded to be of importance for regulation of immune function, and on the basis of this, the recombinant IL1RN variant anakinra has been used clinically to prevent or attenuate systemic inflammation. [5] [6] [7] Recent studies suggest that the IL-1 system and IL1RN in particular may exert important metabolic effects. On the basis of experimental studies, anakinra was given to patients with type 2 diabetes and found to enhance insulin secretion and improve hyperglycemia, although measures of insulin sensitivity were unaffected. [8] [9] [10] [11] With regard to lipid metabolism, IL1R1 knockout mice as well as IL-1/IL-6 double knockout mice get obese, whereas IL1RN knockout mice get leanness and obesity resistance. [12] [13] [14] [15] Thus, IL-1b seems to decrease obesity in mice, whereas IL1RN may promote obesity by suppressing IL-1 effects. As mentioned above, IL1RN is released from adipose tissue, especially in obese individuals. 3, 4 IL1RN has the unique property of being an endogenous inhibitor of the effects of a potent hormone (IL-1), and it is now being exploited clinically for the treatment of both metabolic and inflammatory diseases. However, there is little information about the possible biological effects of endogenous IL1RN in humans in vivo.
In earlier studies, we investigated the association between well-known, common and functional polymorphisms of the IL-1 system and the regulation of body fat. We found several polymorphisms that were associated with different measures of global and regional fat mass in two populations of younger and older Swedish men. However, there were some discrepancies between the associations found in the younger and the older populations. For instance, the well-known IL1RN 86 bp variable tandem repeat (VNTR) was associated with body fat only in the study consisting of young adult men. 16, 17 To further investigate these discrepancies in earlier studies, we now expanded our search to include four genes in the IL-1 gene system. In a systematic manner, using several tagging SNPs in each gene, the major genetic variations of each gene have been analyzed. The aim of this study was to screen for most of the common genetic variation in four genes of the IL-1 gene system to identify single-nucleotide polymorphisms (SNPs) and/or haplotypes, which influence the total body fat mass.
Subjects and methods
Study subjects: young adult men The Gothenburg osteoporosis and obesity determinants (GOOD) study was initiated to determine environmental and genetic factors involved in the regulation of bone and fat mass. Study subjects were randomly identified using national population registers, contacted by telephone, and asked to participate in this study. A total of 1068 men (age, 18.9 ± 0.6 years) from the greater Gothenburg area were included. To be included in the GOOD study, subjects had to be more than 18 and less than 20 years of age and to be willing to participate in the study. There were no other exclusion criteria. Almost half (49%) of the study candidates agreed to participate and were enrolled. 18 The study was approved by the ethics committee at the University of Gothenburg. Informed consent was obtained from all study participants.
Study subjects: elderly men The major findings in the initial screening study in young adult men were replicated in a large population of elderly men. The osteoporotic fractures in men (MrOS) study is a multicenter, prospective study, including older men in Sweden, Hong Kong and the United States. The Swedish MrOS cohort (n ¼ 3014) consists of three subcohorts from three different Swedish cities (n ¼ 1005 in Malmö, n ¼ 1010 in Gothenburg and n ¼ 999 in Uppsala), and the study subjects (men aged 70-81) were randomly identified using national population registers. A total of 45% of the subjects who were contacted participated in the study. To be eligible for the study, the subjects had to be able to walk without aids. There were no other exclusion criteria. 19 The study was approved by the ethics committees at the Gothenburg, Lund and Uppsala Universities. Informed consent was obtained from all study participants.
Assessment of covariates
A standardized questionnaire was used to collect information about the amount of physical activity and smoking. In the GOOD study, physical activity was assessed as hours of physical activity per week as described previously. 18 In the MrOS study, physical activity was the subject's average total daily walking distance, including both walking as a means of exercise and leisure, and as a means of outdoor transportation in activities of daily life. 19 
Assessment of body composition
In the GOOD study, lean tissue mass and fat masses for total body, arm, leg and trunk were determined by using dualenergy X-ray absorptiometry (DXA; Lunar Prodigy DXA, GE Lunar Corp., Madison, WI, USA). In the MrOS Sweden study, lean tissue mass and total fat mass were determined using the Lunar Prodigy DXA (n ¼ 1 997) for subjects investigated in Malmö (n ¼ 998) and Uppsala (n ¼ 997), or the Hologic DXA Hologic QDR 4500/A-Delphi (Hologic, Whaltman, MA, USA; n ¼ 953) for subjects investigated in Gothenburg.
Genotyping GOOD study. A total of 41 SNPs with minor allele frequencies of X5% in four genes in the IL-1 system were selected from HapMapData Rel 21/phasell using a pairwise Blood chemistry Serum was obtained from whole blood using standard procedures, frozen without delay, and stored at -70 C. Leptin was analyzed in serum samples (that had not undergone additional freeze-thaw cycles) using a commercially available kit (active human leptin ELISA, Diagnostic Systems Laboratories Inc., Webster, TX, USA) with a detection limit of 0.05 ng ml
À1
. Intra-and interassay coefficient of variation (CVs) were 6.2 and 5.3%, respectively. IL1RN levels in serum were measured with Fluorokine MAP human IL1RN kit (R&D, Minneapolis, MN, USA) with a detection limit of 27.6 pg ml À1 and an interassay CV of 14%.
Statistical analysis
All SNPs were checked for Hardy-Weinberg equilibrium (HWE) with w 2 -analysis. Linkage disequilibrium (LD) patterns were investigated by calculating pairwise measures of LD (D' and r 2 ) using Haploview 21 . Relationships between total fat and SNPs and/or haplotypes were analyzed with linear regression using covariates. Log phenotypes were used where appropriate in the linear regression model. In the haplotype trend regression of the IL1RN gene, only subjects that were 100% genotyped were included (n ¼ 1020). We screened for haplotype association using a sliding window approach with increasing window size. Software used were Haploview 21 , Helix Tree and SPSS. Values are given as mean ± s.d. All tests were two-tailed and conducted at the 5% significance level.
Results
General characteristics of the population-based study consisting of a group of healthy well-characterized young adult men, who are homogenous with respect to age and ethnicity, are shown in Table 1a . To investigate whether SNPs in the IL-1 system are associated with body fat, we analyzed several SNPs in four genes in this system in relation to the primary outcome total body fat mass as measured by DXA. The total fat mass was found to have no previously described associations with one individual SNP and several haplotypes in the IL1RN gene. Therefore, data from this gene are emphasized in this study.
Characteristics of the SNPs in the IL-1 gene family
We successfully genotyped 38 SNPs distributed across four genes of the IL-1 system. Of these 38 SNPs, 17 were in the IL-1 receptor 1 (IL1R1) gene, 3 were in the IL-1a (IL1a) gene, 3 were in the IL-1b (IL1b) gene and 15 were in the IL-1 receptor antagonist (IL1RN) gene. The general localizations within the genes, allele and genotype frequencies, and HWE are shown in Table 2 for the IL1RN gene and in Supplementary  Table S1 for the IL1R1, IL1A and IL1B genes. The w 2 -analysis showed no deviation from HWE for any of the 38 investigated SNPs. The allelic frequencies obtained are consistent with the dbSNP allelic frequencies for the European population.
Pairwise LD tests between consecutive SNPs showed that the LD (D 0 ) values were mostly high and significant across the IL1RN gene, indicating that the recombination events are rare in the IL1RN gene ( Figure 1 ). Similar patterns were seen in the three other studied genes (data not shown). The intergenic LDs between the IL1A, IL1B and IL1RN genes were Associations between individual SNPs in the IL1RN gene and fat mass The initial statistical analysis was performed with a linear regression model with total body fat mass as the primary outcome variable and age, current physical activity, current smoking status, height and total lean mass as covariates. Backward selection was used to determine whether these covariates were suitable. This analysis showed that current physical activity and total lean mass had highly significant associations with total fat (Po0.01), and these two covariates were hence included in the upcoming analysis. For each SNP, a multiple linear regression analysis with the primary outcome total body fat mass were performed (Table 3a) . After correcting for multiple inference, the two best SNPs were rs419598 (J, Pc ¼ 0.059) and rs4252041 (L, Pc ¼ 0.034).
As the next step, we investigated whether the two above selected SNPs (J and L) were also associated with our secondary outcomes by using multiple linear regressions. This analysis showed associations between the L (C4T) SNP and the primary outcome total body fat mass, as well as the secondary outcomes total fat %, body weight, body mass index (BMI) as well as for regional measures of fat (Table 4a ). The L (C4T) SNP was not associated with serum leptin, serum IL1RN or lean tissue mass (Table 4a ). For the J (T4C) SNP, multiple linear regression showed associations with total body fat mass, total fat %, body weight, serum leptin and regional measures of fat, serum IL1RN, but not BMI or lean tissue mass (Table 4b) . We next investigated the interactions between the J and L SNPs in relation to the primary outcome total body fat. When the J and L SNPs were entered into the same linear regression model, this enhanced the predictive power of the model (Dr 2 ¼ 0.013, P ¼ 0.001; Table 3b ) compared to either SNP analyzed individually (Table 3a) . The fact that both the J and the L SNPs remained significant (P ¼ 0.016 and P ¼ 0.009, respectively) when entered together into the linear regression model suggests a significantly added contribution of both the J and L SNPs in this model, indicating the existence of haplotypes that have better predictive value.
Associations between haplotypes in the IL1RN gene and body fat Having observed significant associations between individual SNPs in the IL1RN gene and total body fat mass, we attempted to investigate haplotypes in relation to the primary outcome total body fat mass. This was performed using a moving window approach, which showed an emerging peak in the P-value plot (Figure 2 ) at the 3 0 end of the IL1RN gene. When the window size was sequentially increased, this P-value peak reached its maximum when the window consisted of five adjacent SNPs (KLMNO) at the 3 0 end of the IL1RN gene. All possible haplotypes within the KLMNO window were identified using the expectation-maximization algorithm, and their frequencies were determined (Supplementary Table  S2 ). These haplotypes were analyzed in relation to total body fat mass using a stepwise multiple linear regression model. This model identified three haplotypes, which together had Table 5 ). The corrected P-value was still highly significant (Pc ¼ 0.0007). The haplotypes in the KLMNO window that remained after the stepwise selection were, TCGAG, which was associated with increased fat mass, and TTGGG and TCGAT, which were associated with decreased fat mass (Table 5) . Next, the previously published J SNP (which by itself was associated with increased total fat mass in this study) was included as a covariate for the haplotypes. This resulted in the exclusion of the positive association between the TCGAG and fat mass in the model, suggesting a high LD between this haplotype and the J SNP. The associations between the two remaining haplotypes and decreased fat mass still remained highly significant in this model (Dr 2 ¼ 0.014; P ¼ 0.0004; Table 5 ), indicating that the two remaining haplotypes provide additional information.
Replication of major findings
To confirm the association between the J (T4C) and L (C4T) SNPs and fat mass, which we found in young adult Swedish men, we genotyped 3014 70-81-year-old men from the same general population. The general characteristics of the population consisting of elderly men are shown in Table 1b . The allele frequencies were virtually the same in both studies (Tables 2 and 6 ). LD measures were calculated D 0 ¼ 0.94 and r 2 ¼ 0.01, respectively, and both SNPs were in HWE. As the parameters measured in the population-based study chosen for replication were slightly different, the statistical analysis was again started with a determination of suitable covariates. A linear regression model was used with total body fat mass as the primary outcome variable and age, current physical activity, current smoking status, height, total lean mass and type of DXA machine as covariates. The latter covariate was necessary, as this study population have been measured at three different sites in Sweden using different types of DXA machines. Backwards selection showed that current physical activity, current smoking status, height, DXA type and total lean mass had highly significant associations with total body fat mass (Po0.01), and these five were hence chosen as covariates in the following analysis. Multiple linear regression analysis of the primary outcome total body fat mass showed significant associations with the L (C4T), but not the J (T4C) polymorphisms in the IL1RN gene (P ¼ 0.025 and 0.095 respectively; Table 6 ). . 21 The color reproduction of this figure is available on the html full text version of the manuscript.
IL1RN Haplotypes and fat mass N Andersson et al

Discussion
The relation between the IL-1 system and metabolism has attracted growing interest in recent years, not least because there is a possibility that the endogenous IL-1 receptor antagonist, IL1RN, may be used clinically for treatment of metabolic as well as immune-related conditions. 5, 7, 22 In this study, we performed the first systematic investigation of how genetic variations in the IL-1 gene system are associated with total body fat mass and obesity in a well-characterized population of 1068 healthy young men within a 2-year age span. By using this approach, we identified one SNP that have not been described previously in the IL1RN gene, which was clearly associated with body fat mass, as also confirmed in another population consisting of over 3000 elderly men. Moreover, a more detailed analysis revealed that the SNP identified in this study was part of a group of three haplotypes, consisting of five adjacent SNPs, with strong associations with total body fat mass. Therefore, these data support the hypothesis that the IL-1 system, especially endogenous IL1RN, exerts metabolic effects in humans.
The possibility of interactions between the IL-1 system on the one hand and obesity and obesity-related conditions on the other gains support from studies in mice with gene knockouts. It seems that both endogenous IL1RN production and prevention of the biological effects of IL-1 by other means can promote obesity in experimental animals. We recently observed that Il1r1 knockout mice get mature onset obesity, 13 in a similar way as previously shown for IL-6 deficient mice, 23 whereas hypothalamic IL-1 activity may be less important for the regulation of body fat in young rodents. 24 Iwakura and colleagues 12 reported that mice lacking both IL-6 and IL-1b get obesity at a younger age.
On the other hand, Il1rn gene knockout, which presumably associated with enhanced IL-1 activity, results in leanness and obesity resistance. 14, 15 As expected, obese IL1RN knockout mice have impaired glucose tolerance, whereas serum insulin levels decreased in the Il1rn knockout mice. 13, 15 Taken together, these findings imply that there is a dose-response relation between a wide range of IL-1 activity levels and body fat. The mechanism by which IL-1 activity prevents obesity is unknown, but on the basis of the data published by Meier and Rothwell, it has been suggested that IL-1 mediates some of the antiobestiy effect of leptin at the central nervous system level and that this effect might be inhibited by IL1RN produced by fat tissue in obese individuals. 3, 25, 26 Such a mediator effect of hypothalamic IL-1 is supported by more recent data. 24 Moreover, there is evidence that proopiomelanocortin-expressing neurons in the arcuate nucleus have a key role in mediating body weight suppression by IL-1, but there are also results suggesting that the melanocortin system conversely can stimulate IL-1 expression.
27-29
Finally, it is possible that the brain stem is of importance for effects by IL-1 on metabolism. 30 Expression of IL1RN is decreased in pancreatic b cells from patients with type 2 diabetes, 9 and IL-1 can exert deleterious effects on b cells in vitro. 10, 11 Recently, it was reported that treatment with the recombinant human IL1RN variant anakinra results in improved b-cell function, decreased glycated hemoglobin and decreased systemic inflammation, but not improved insulin sensitivity. 8 Taken together, these crucial studies provide evidence that IL1RN in the short term can improve diabetes. On the other hand, Meier et al. 26 have
shown that IL1RN is produced by body fat and that circulating levels of IL1RN are associated with body fat mass. Moreover, there is evidence from mice that endogenous IL-1 is suppressing obesity and blood glucose, whereas IL1RN is enhancing body fat mass and thereby blood glucose as well. 12, 13, 15 It is possible that the induction of obesity in the long term may counteract the improved glucose metabolism that would result from the anti-inflammatory effect of decreased IL-1 activity. Further studies needed to evaluate these complex and partly counteracting effects. In earlier studies, Strandberg et al. 16 and Um et al. 31 found
an association between the well-known IL1RN 86 bp VNTR (in complete LD with the J SNP in this study) 32 and body fat It is of importance that the major findings of this study that the L SNP is associated with fat mass in young adult men was replicated in another population-based study consisting Figure 2 A P-value plot from haplotype trend regression (HTR). A moving HTR window is used; the haplotype frequencies within each window are estimated by the expectation-maximization (EM) algoritm. The P-value at any specific plot location is from the regression, which was performed for the window that contains the indicated markers. P-values are full versus reduced model (haplotypes þ non-haplotype covariates vs non-haplotype covariates only) calculated on log-transformed response (tissue fat mass) by linear regression with tissue lean mass and present physical activity (hours per week) as covariates (modified from Helix tree).
IL1RN Haplotypes and fat mass N Andersson et al of older men. However, it is of interest to investigate whether this association holds true in other ethnic groups as well as in women.
The subjects of the GOOD study have been shown to be representative of the general young male population in Gothenburg with respect to height, weight and BMI. 33 Such an analysis cannot been made in the MrOs study because of limited information in public registers on elderly men. Moreover, the subjects also had to be able to walk without aids to be eligible for the study. Thus, it cannot be excluded that the inclusion criteria have introduced a bias compared with the general population by selecting a somewhat healthier subpopulation. However, in general, both the GOOD and the MrOs studies have relatively high participation rates (49 and 45%, respectively). Recombinant IL1RN is already used in clinical practice for various inflammatory maladies and has been suggested to have beneficial clinical effects on metabolic diseases. 6, 8, 34 
